-
100 Days Mission: “landmark collaboration” to protect people against future pandemics
europeanpharmaceuticalreview
June 04, 2021
Governments and life science leaders agree to work towards slashing the time to develop and deploy interventions and diagnostics for future pandemic threats to 100 days.
-
UK approves Janssen COVID-19 Vaccine
europeanpharmaceuticalreview
June 03, 2021
The Janssen COVID-19 Vaccine has been granted conditional marketing authorisation for use in people aged 18 and over in the UK.
-
UK approves J&J’s one-dose COVID-19 vaccine
pharmatimes
June 01, 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine.
-
60 million doses of COVID-19 vaccine administered in UK
worldpharmanews
May 25, 2021
Health services across the UK have now administered a total of around 60.6 million vaccines since 8 December, including around 37.9 million people with their first dose (72%) and 22.6 million with both doses (43%), ensuring they have the strongest ...
-
COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research
expresspharma
May 24, 2021
A new study by health officials in England shows for the first time that two doses of COVID-19 vaccines are “highly effective” against the B1.617.2 variant first identified in India.
-
UK trial tests third doses of COVID-19 vaccines
pharmatimes
May 20, 2021
A clinical trial has launched in the UK to test the safety and effectiveness of administering a third dose of seven different COVID-19 vaccines.
-
Oxford Immunotec partners with UK COVID-19 human challenge study
pharmatimes
May 19, 2021
UK diagnostic company Oxford Immunotec has collaborated with the UK COVID-19 human challenge study to analyse the T cell responses to SARS-CoV-2 infection in participants using its T-SPOT Discovery testing kit.
-
NAO report finds UK was ‘not as prepared for pandemic as it could have been’
pharmatimes
May 19, 2021
A new report from the National Audit Office (NAO) has found that the UK was not as prepared for the COVID-19 pandemic as it could have been.
-
MedPharm Expands Formulation Development Labs in the UK
contractpharma
May 18, 2021
MedPharm Ltd, a global provider of formulation and development services for topical and transdermal products, has announced a £1.5 million refurbishment that will increase laboratory space in the UK by 30%.
-
Abbott’s AI-powered coronary imaging platform deployed in the UK
pharmatimes
May 14, 2021
Abbott UK’s artificial intelligence- (AI) powered coronary imaging platform has been offered to the first heart attack patients in the country at the Royal Free Hospital in London.